MindMaze Therapeutics Begins Enrollment for SwissNeuroRehab Study, Enhancing At-Home Stroke Recovery#Switzerland#Geneva#MindMaze_Therapeutics#SwissNeuroRehab#Neurorehabilitation
MindMaze Therapeutics Begins Enrollment for SwissNeuroRehab Study, Enhancing At-Home Stroke Recovery
MindMaze Therapeutics has started enrolling participants in its groundbreaking SwissNeuroRehab study, which aims to improve at-home stroke rehabilitation and reimbursement in Europe.
third-news.com
July 1, 2026 at 5:28 AM
MindMaze Therapeutics Begins Enrollment for SwissNeuroRehab Study, Enhancing At-Home Stroke Recovery#Switzerland#Geneva#MindMaze_Therapeutics#SwissNeuroRehab#Neurorehabilitation
Upcoming Investor and Industry Conferences Featuring MindMaze Therapeutics' Innovations#Switzerland#medical_technology#Geneva#Neurotherapeutics#MindMaze_Therapeutics
Upcoming Investor and Industry Conferences Featuring MindMaze Therapeutics' Innovations
MindMaze Therapeutics is set to showcase its revolutionary neurotherapeutic solutions at several key investor and industry conferences throughout fall 2026.
third-news.com
September 1, 2026 at 5:46 AM
Upcoming Investor and Industry Conferences Featuring MindMaze Therapeutics' Innovations#Switzerland#medical_technology#Geneva#Neurotherapeutics#MindMaze_Therapeutics
MindMaze Therapeutics Releases 2026 Half-Year Results and Strategic Updates on Growth#Switzerland#Geneva#MindMaze_Therapeutics#SwissNeuroRehab#Neurorehabilitation
MindMaze Therapeutics Releases 2026 Half-Year Results and Strategic Updates on Growth
MindMaze Therapeutics shares its 2026 half-year results, highlighting significant progress in neurotherapeutics, commercial growth, and innovative studies aimed at enhancing patient recovery.
third-news.com
August 27, 2026 at 5:38 AM
MindMaze Therapeutics Releases 2026 Half-Year Results and Strategic Updates on Growth#Switzerland#Geneva#MindMaze_Therapeutics#SwissNeuroRehab#Neurorehabilitation
MindMaze Therapeutics Welcomes Dr. John W. Krakauer as Strategic Advisor to Boost U.S. Expansion#Switzerland#Geneva#Neurotherapeutics#MindMaze_Therapeutics#John_W._Krakauer
MindMaze Therapeutics Welcomes Dr. John W. Krakauer as Strategic Advisor to Boost U.S. Expansion
MindMaze Therapeutics has appointed Dr. John W. Krakauer as a strategic advisor to enhance their growth phase in the U.S. healthcare market.
third-news.com
August 12, 2026 at 5:47 AM
MindMaze Therapeutics Welcomes Dr. John W. Krakauer as Strategic Advisor to Boost U.S. Expansion#Switzerland#Geneva#Neurotherapeutics#MindMaze_Therapeutics#John_W._Krakauer
MindMaze Therapeutics Optimizes Structure with Strategic Financial Moves#Switzerland#Geneva#Neurotherapeutics#MindMaze_Therapeutics#Neuro.io
MindMaze Therapeutics Optimizes Structure with Strategic Financial Moves
MindMaze Therapeutics has streamlined its organizational structure and updated its strategic funding with Neuro.io, enhancing its focus on neurological therapies.
third-news.com
August 10, 2026 at 5:35 AM
MindMaze Therapeutics Optimizes Structure with Strategic Financial Moves#Switzerland#Geneva#Neurotherapeutics#MindMaze_Therapeutics#Neuro.io